Some patients are naturally more responsive to GLP-1 receptor agonists than others due to various physiological factors
While it is still not FDA-approved, it is being clinically tested and studied as a solution for obesity
Diabetologia 53 (1), 153159
[CrossRef] [PubMed] [Google Scholar] The evolution of technology and physical inactivity: The good, the bad, and the way forward
Also, the number of follicles larger than 17 mm, the concentration of estradiol and the thickness of the endometrium were significantly higher in the L-carnitine group [9]
Large randomized controlled trials such as STEP 1 and STEP 6 have reported weight losses of 1015% after 68 weeks of semaglutide treatment, confirming its clinical efficacy [16, 23]